FIRST MIDWEST BANK TRUST DIVISION - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST MIDWEST BANK TRUST DIVISION ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2021$3,992,000
+11.1%
76,281
-20.8%
0.51%
+0.4%
Q3 2021$3,592,000
+8.6%
96,358
+18.9%
0.51%
+15.1%
Q2 2021$3,308,000
+5.4%
81,031
-12.4%
0.44%
+3.0%
Q1 2021$3,139,000
-26.8%
92,504
-31.4%
0.43%
-30.5%
Q4 2020$4,290,000
-27.4%
134,891
-41.4%
0.62%
-32.6%
Q3 2020$5,907,000
-14.8%
230,203
-14.8%
0.92%
-18.4%
Q2 2020$6,937,000
+158.5%
270,219
+54.8%
1.13%
+130.8%
Q1 2020$2,684,000
-23.2%
174,594
+71.4%
0.49%
+3.4%
Q4 2019$3,496,000
-55.1%
101,889
-83.0%
0.47%
-57.3%
Q2 2019$7,791,000
+80.9%
600,236
+69.8%
1.11%
+89.6%
Q1 2019$4,307,000
+15.6%
353,592
+8.1%
0.59%
+4.1%
Q4 2018$3,727,000
-16.0%
327,226
+60.0%
0.56%
-5.7%
Q3 2018$4,437,000
+40.6%
204,470
+14.5%
0.60%
+33.6%
Q2 2018$3,156,000
+41.2%
178,590
+68.2%
0.45%
+45.1%
Q1 2018$2,235,000
-17.5%
106,182
-43.3%
0.31%
-8.9%
Q4 2017$2,709,000
-7.1%
187,120
+1.2%
0.34%
-5.1%
Q3 2017$2,917,000
+50.2%
184,836
+18.2%
0.36%
+49.0%
Q2 2017$1,942,000
+16.8%
156,349
+52.8%
0.24%
+17.7%
Q1 2017$1,663,000102,3260.20%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders